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Background. Heparan sulfate proteoglycans (HSPGs) use highly sulfated polysaccharide side-chains to interact with several
key growth factors and morphogens, thereby regulating their accessibility and biological activity. Various sulfotransferases
and sulfatases with differing specificities control the pattern of HSPG sulfation, which is functionally critical. Among these
enzymes in the mouse are two secreted 6-O-endosulfatases, Sulf1 and Sulf2, which modify HSPGs in the extracellular matrix
and on the cell surface. The roles of Sulf1 and Sulf2 during normal development are not well understood. Methods/Results.
To investigate the importance of Sulf1 and Sulf2 for embryonic development, we generated mice genetically deficient in these
genes and assessed the phenotypes of the resulting secreted sulfatase-deficient mice. Surprisingly, despite the established
crucial role of HSPG interactions during development, neither Sulf1-n o rSulf2-deficient mice showed significant
developmental flaws. In contrast, mice deficient in both Sulf1and Sulf2 exhibited highly penetrant neonatal lethality. Loss
of viability was associated with multiple, although subtle, developmental defects, including skeletal and renal abnormalities.
Conclusions. These results show that Sulf1 and Sulf2 play overlapping yet critical roles in mouse development and are
redundant and essential for neonatal survival.
Citation: Holst CR, Bou-Reslan H, Gore BB, Wong K, Grant D, et al (2007) Secreted Sulfatases Sulf1 and Sulf2 Have Overlapping yet Essential Roles in
Mouse Neonatal Survival. PLoS ONE 2(6): e575. doi:10.1371/journal.pone.0000575
INTRODUCTION
Normal developmental processes of metazoans depend upon cell-
cell communication, which is mediated by a diverse yet highly
conserved set of secreted protein factors. Genetic analysis of
embryonic development in C. elegans, Drosophila, zebrafish, and
mouse has revealed the biological importance of heparan sulfate
proteoglycans (HSPGs) in regulating the activity of multiple
secreted growth factors and morphogens in various developmental
processes [1,2]. Among these factors are the ligands of the
fibroblast growth factor (FGF), bone morphogenetic protein
(BMP), wingless/WNT, and Hedgehog (Hh) pathways. HSPGs
have been shown to regulate cell signaling positively or negatively,
depending on pathway and context.
HSPGs such as glypicans, syndecans, agrins, and perlecans are
proteins modified with heparan sulfate during their biosynthetic
transit through the Golgi apparatus. Following the addition of
a tetrasaccharide linker to specified serines in the polypeptide
backbone, the exostosin (EXT) enzymes catalyze the addition of
unbranched repeats of the glucuronic acid, N-acetylglucosamine
disaccharide [3,4]. The uniformity of this simple disaccharide
repeat is then diversified by the activity of several other biosynthetic
enzymes, including sulfotransferases with differing specificities,
N-deacetylase/N-sulfotransferases (NDSTs), and an epimerase,
eventually producing a polysaccharide sidechain of astonishing
complexity [5,6]. The sulfotransferases catalyze the addition of
sulfate to the N,3 - O, and 6-O positions of N-acetylglucosamine and
the 2-O position of iduronic acid. The degree and specific pattern
of sulfation is determined, in a tissue-specific manner, by the
expression of these biosynthetic enzymes [7]. The sulfation pattern
of HSPGs is critical for determining the specificity and affinity of
binding to growth factors and morphogens [5].
Heparan sulfate modification of proteins is essential for mouse
development. Embryos deficient for the Ext1 glycosyltransferase,
and hence devoid of nearly all heparan sulfate, die during
gastrulation [8]. The relevance of sulfation pattern of HSPGs to
normal development has been underscored by the analysis of the
neonatal lethality and pleiomorphic phenotypes of Ndst1- and
Hs2st-deficient mice [9–11]. Whereas Ndst1-deficient embryos
exhibit cerebral and pulmonary hypoplasia and craniofacial
defects, Hs2st-deficient embryos show cerebral and renal hypo-
plasia accompanied by skeletal and eye defects. Furthermore,
inhibition of the different 6-O-sulfotransferase genes has profound
effects on muscle and vascular development in zebrafish [12,13].
An additional regulatory level of HSPG sulfation status was
recently suggested by the discovery and cloning of a novel class of
secreted sulfatase enzymes [14,15]. These proteins, named Sulf1
and Sulf2 in the mouse, can act on HSPGs on the cell surface as
well as within the Golgi apparatus, thereby affecting sulfation
status ex post facto [15,16]. The hydrolytic activity of these enzymes
is specific to the 6-O-sulfate of N-acetylglucosamine [15,17].
Because these sulfatases are found in soluble as well as cell surface-
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mous or paracrine activity.
Given the critical role of regional HSPG sulfation patterns
during development, we sought to assess the importance of Sulf1
and Sulf2 during mouse development. To this end, we generated
mouse strains with disruption of the Sulf1 or Sulf2 genes. We report
here that deficiency in either Sulf1 or Sulf2 alone did not
appreciably affect normal developmental or physiological pro-
cesses. In contrast, disruption of both Sulf1 and Sulf2 simulta-
neously resulted in high-penetrance perinatal lethality in conjunc-
tion with multiple subtle developmental defects. These results
indicate that Sulf1 and Sulf2 play overlapping and essential role(s)
during development. Our results confirm and expand upon the
recently reported phenotypes of sulfatase-deficient mice by
Lamanna et al. [17,18], but differ from the phenotypes of the
Sulf2-deficient animals described by Lum et al. [19].
MATERIALS AND METHODS
The Institutional Animal Care and Use Committee approved all
protocols used in this study.
Sulf1 and Sulf2 targeting
Embryonic stem (ES) cells with retroviral gene trap vectors
inserted into the Sulf1 (OST352220) and Sulf2 (OST311938) loci
were generated in collaboration with Lexicon Genetics (The
Woodlands, TX) using methods described previously [20]. Sulf1
was disrupted by insertion of the VICTR48 construct; this allele is
therefore named Sulf1
Gt(VICTR48)352220Lex. Sulf2 was disrupted by
the VICTR37 retroviral construct, which included a promoterless
b-galactosidase cassette in addition to the Neomycin resistance
gene. The Sulf2 allele generated by the insertion mutation is
named Sulf2
Gt(VICTR37)311938Lex. The insertion sites were deter-
mined by sequence analysis. The Sulf1-o rSulf2-targeted 129/
SvEvBrd ES cells were microinjected into blastocysts and
implanted into C57BL/6J females. Germline transmission was
assessed in F1 pups by PCR analysis of genomic DNA.
Heterozygous mice were either intercrossed to assess the
phenotypes on a mixed strain background or backcrossed onto
the C57BL/6N background. Unless otherwise specified, the results
presented herein were performed using the N4 (Sulf2), or N5 or N6
(Sulf1) backcross generations. For simplicity’s sake, we refer to the
gene trap alleles of the genes as Sulf1
2 and Sulf2
2 and the wild-
type alleles as Sulf1
+ and Sulf2
+.
Generation of mice deficient for both Sulf1 and
Sulf2
Sulf1
2/2 (N3, C57BL/6N) mice were crossed to Sulf2
2/2 (N2,
C57BL/6N) mice to generate F1 Sulf1
+/2 Sulf2
+/2 mice. F1 mice
were intercrossed to assess the viability of mice with the different
possible genotypes. To generate sufficient Sulf1
2/2 Sulf2
2/2 mice
to study, we routinely intercrossed F2 Sulf1
+/2 Sulf2
2/2 to Sulf1
2/
2 Sulf2
+/2 mice to produce study cohorts with Sulf1
+/2 Sulf2
+/2
mice as controls.
Genotyping of Sulf1 and Sulf2 alleles
We utilized a PCR genotyping strategy to detect the wild type and
disrupted alleles of Sulf1 and Sulf2. Tail DNA was prepared using
the Extract-N-Amp extraction kit following the manufacturer’s
protocol (Sigma, St. Louis, MO). PCR conditions were as follows:
94uC for 4 min., 1 cycle; 94uC for 60 s, 60uC for 30 s, 72uC for
60 s (30–35 cycles); 72uC for 10 min., 1 cycle. For genotyping of
tails from neonate and young adult mice, 30 cycles were sufficient.
We increased the cycle number to 35 when detecting DNA from
embryonic tissue.
The retroviral insertion in the Sulf1 locus was detected using
primers Sulf1-R1 and LTR, which generated a 334-bp product.
We detected the wild type Sulf1 allele using primers Sulf1-F and
Sulf1-R1, which produced a 459-bp amplicon. Using a similar
strategy, the insertion allele in the Sulf2 locus were detected using
primers Sulf2-R and LTR2, producing a 440-bp band; the wild-
type Sulf2 allele was amplified with primers Sulf2-F2 and Sulf2-R,
making a 759-bp product. The appropriate three-primer sets were
used simultaneously without evidence of interference when
evaluating both modified genes. Sulf1; Sulf2 mice were genotyped
as above, amplifying the Sulf1 and Sulf2 loci in separate reactions.
Sequences of genotyping primers were as follows, from 59 to 39:
LTR, ATA AAC CCT CTT GCA GTT GCA TC; Sulf1-F, CCG
CAA AGA CTT GGA ATT AAC TC; Sulf1-R1, CTT CAC
ACA CTC CAC ACT CAG TTC T; LTR2, AAA TGG CGT
TAC TTA AGC TAG CTT GC; Sulf2-F2, TTG ACT TTC
TGG GGA GGG TGG ATG; and Sulf2-R, GAT GGG CCA
CTC CTG AGA TAA CCT G.
RNA purification and quantitative RT-PCR
For quantitative real-time RT-PCR (Q-RT-PCR), total RNA was
isolated using the RNeasy kit essentially according to the
manufacturer’s protocol, including the on-column DNase di-
gestion (Qiagen, Valencia, CA). Immediately prior to column
purification, frozen tissue was homogenized in RLT buffer
containing b-mercaptoethanol using a stator homogenizer fol-
lowed by a QiaShredder column (Qiagen). To remove all
contaminating genomic DNA, we re-purified the eluted RNA
over a fresh RNeasy column, including a second DNase treatment.
This routinely reduced the amplification of a control reaction
omitting reverse transcriptase to below the limit of detection,
allowing us to conclude that signal was indeed due to RNA and
not contaminating genomic DNA.
Q-RT-PCR was done according to the Taqman protocol
(Applied Biosystems, Foster City, CA). Using 100 ng total RNA
per 50 ml reaction, we detected and quantitated the amplification
products using an ABI 7500 system (Applied Biosystems),
normalizing to either the GAPDH or RPL19 housekeeping genes.
Relative changes in gene expression were quantitated using the
2
2DDCt method [21]. Primer/probe sets used were as follows, with
forward primers denoted by F, reverse primers by R, and FAM/
TAMRA-labeled probes as T: Sulf1-4535F, CCT CGA CGT
GCT AAA CTT GA; Sulf1-4611R, TAT TCC CGC AGG ATT
TAT TTC; Sulf1-4556T, TAG CAG AAA GGC ATG GCT
CAC AAT G; Sulf2-3364F, CCC TTG AGC TTT CAG ACA
TTT; Sulf2-3428R, CAG TTC TGG GAT GGA TAA CAA A;
Sulf2-3386T, TTC CTG CCC GGG ATT CGT TC; RPL19-F2,
AGA AGG TGA CCT GGA TGA GAA; RPL19-R2, TGA TAC
ATA TGG CGG TCA ATC T; RPL19-T2, CTT CTC AGG
AGA TAC CGG GAA TCC AAG; GAPDH-F, ATG TTC CAG
TAT GAC TCC ACT CAC G; GAPDH-R, GAA GAC ACC
AGT AGA CTC CAC GAC A; and GAPDH-T, AAG CCC
ATC ACC ATC TTC CAG GAG CGA GA.
Whole-mount embryo RNA in situ hybridization
Embryos were harvested at E8.5-E12.5 (with noon of the day the
vaginal plug was observed designated as E0.5) and fixed in freshly
prepared 4% paraformaldehyde (PFA) in PBS (pH 7.4) overnight
at 4uC. Primers used to amplify the Sulf1 transcript from a mouse
embryo cDNA library to TOPO-clone into pCR-II-TOPO
(Invitrogen, Carlsbad, CA) were Sulf1-wmISH-S, ACC AGT
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CAT CCC ATA ACT. Following sequencing to ensure fidelity of
the amplification and orientation of insertion, we generated
antisense, DIG-labeled probe from linearized plasmid template
using the mMESSAGE mMACHINE kit (Ambion, Austin, TX),
following the manufacturer’s instructions. Hybridization and
detection of DIG-labeled probe were done according to standard
protocols.
Section RNA in situ hybridization
Following fixation in freshly prepared 4% PFA in PBS (pH 7.4)
overnight at 4uC, we equilibrated embryos (E9.5–E12.5) overnight
in 30% sucrose in PBS, followed by 1 h in Tissue-Tek O.C.T.
(Sakura). Specimens then were embedded in fresh O.C.T. and
frozen in an ethanol/dry ice bath. In situ hybridization was carried
out on 20-mm transverse sections of wild type embryos. To
generate
35S-radiolabeled RNA probe for in situ hybridization, we
used the mRNAlocator kit (Ambion) according to the included
instructions. The template for the probe synthesis was a PCR
product with a T7 promoter included in the primer, using the
following primers: Sulf1-sISH-S, TAT CCG GTG CAA GCA
ACA T; Sulf1-sISH-T7-AS, TAA TAC GAC TCA CTA TAG
GGA GGC TGT TCA GAT GCA GGG TTT G; Sulf2-sISH-S,
CCC ACA ACT TCC TCT TCT GC; and Sulf2-sISH-T7-AS,
TAA TAC GAC TCA CTA TAG GGA GGC CCA TAG CTG
TCC CAG TGA T.
In situ hybridization using DIG-labeled probes specific to
Collagen Type X and Collagen Type II was performed on para-
formaldehyde-fixed, paraffin-embedded tissue, as previously de-
scribed [22].
b-Galactosidase expression pattern analysis
All solutions were made in 0.1 M phosphate buffer (pH 7.3).
Embryos (E10.5–E12.5) were washed in unadulterated buffer and
then fixed for 30–45 min in buffer containing 0.2% glutaralde-
hyde, 5 mM EGTA, and 2 mM MgCl2. Embryos were then
washed 3615 min in buffer containing 2 mM MgCl2, 0.01%
deoxycholate, 0.02% Nonidet-P40 and stained in the dark for 1–
12 hours at room temperature in buffer containing 5 mM
K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2, 0.02% NP-40,
and 1 mg/ml 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside
(X-gal, IBI Shelton Scientific, Peosta, IA). Embryos were then
washed in PBS (pH 7.4) and post-fixed in neutral buffered 10%
formalin (NBF). Stained specimens were evaluated as whole
mounts and then, in selected instances, in 12-mm-thick transverse
cryosections of O.C.T.-embedded material.
Skeletal preparations
Near-term (E18.5) fetuses or neonates were killed, flayed,
eviscerated, and fixed in 100% ethanol for 1–2 days, followed
by an overnight acetone treatment. Specimens were stained in
0.015% alcian blue, 0.005% alizarin red in 5% acetic acid, 60%
ethanol for 2–3 days at room temperature; washed briefly in tap
water; then cleared in 1% KOH for several days. Cleared
specimens were passed through a series of glycerol solutions of
increasing concentration prior to visualization on a Zeiss dissecting
microscope.
Micro-computed tomography (mCT) image
acquisition
The mouse embryos were imaged with a mCT40 (SCANCO
Medical, Basserdorf, Switzerland) x-ray micro-computed tomog-
raphy system. A sagittal scout image, comparable with a conven-
tional planar x-ray, was obtained to define the start and end point
for the axial acquisition of a series of mCT image slices. The
location and number of axial images were chosen to provide
complete coverage of the embryo. The embryos were imaged with
air as the background media. The mCT images were generated by
operating the x-ray tube at an energy level of 45 kV, a current of
177 mA and an integration time of 300 milliseconds. Axial images
were obtained at an isotropic resolution of 16 mm.
Analysis of mCT images
The relationship between the image intensity values and bone
mineral density was assumed to be linear and was obtained by
scanning a 97% pure hydroxyapatite (HA) sample (2.91 gHA/
cm
3). Three-dimensional (3D) surface renderings were created
from the mCT data with the use of Analyze (AnalyzeDirect Inc.,
Lenexa, KS), an image analysis software package. The bone
surface renderings were generated by applying a bone mineral
density of threshold of 0.54 gHA/cm
3. The bones of interest
(femur, humerus, supraoccipital, interparietal, parietal, frontal,
basisphenoid and basioccipital) were extracted for quantitative
analysis by the applying a series of image analysis steps (thresh-
olding, morphological filtering and region growing operations) to
the volumetric image data. For the long bones, the distance
between the ends of the bone was measured as a straight line and
an average was computed using the contralateral bone measure-
ments. The volume (mm
3) and mean bone density (gHA/cm
3)o f
the defined bones was measured and an average was obtained for
the ipsilateral and contralateral bones for each embryo.
Necropsy and histological preparation of
conceptuses and neonates
Fetuses (E15.5 and E18.5) were removed from the uteri of
anesthetized dams. The tip of each fetus’s tail was harvested for
genotyping by PCR, after which the fetus and placenta were fixed
by immersion in either 4% PFA, 10% NBF, or Bouin’s solution.
Some fetuses were bisected longitudinally just to the left of the
midline, while others were decapitated so that the heads could be
cut coronally. A few neonates (including placentas) were handled
in a similar manner. Fixed tissues were processed into paraffin
using a conventional protocol. Serial 5-mm-thick coronal sections
of each head block were acquired at several steps, each separated
by a distance of 250 mm. Serial 5-mm-thick sections of each torso
block were acquired at several steps, each separated by a distance
of 500 mm. Serial sections at each step were stained with
hematoxylin and eosin (H&E) or cresyl violet (to better delineate
subcellular characteristics of neural cells). Lesions were scored
(with foreknowledge of the fetus’s genotype) using a tiered, semi-
quantitative grading scale: absent, minimal, mild, moderate,
marked. Subsequently, a coded (‘‘blinded’’) histopathological
assessment for a given organ was performed by inverting all slides
and then sorting them into groups using criteria established in the
uncoded examination.
Mouse embryonic fibroblast isolation
E12.5 embryos were dissected from the extraembryonic tissues in
PBS, then the liver and head were removed. After mincing with
scissors, the remaining tissue was digested in 0.1% trypsin/EDTA
in PBS for 20 min at 37uC, with mixing every 5 min. After
washing twice with culture medium (DMEM with 10% fetal
bovine serum (FBS), 2 mM L-glutamine, and penicillin/strepto-
mycin), the cells from a single embryo were plated in a 25-cm
2
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frozen in aliquots or used immediately for signaling experiments.
FGF signaling in embryonic fibroblasts
First- or second-passage fibroblasts were serum-starved overnight
in assay medium containing 0.5% FBS at a density of 10
5 cells per
well of a 6-well plate. The following day, prewarmed FGF1- or
FGF2-containing assay medium (or assay medium lacking FGF)
was added to the cells, which were then returned to the 37uC
incubator for 10 minutes. Cells were lysed for 15 minutes at 4uC,
with rocking, in 16RIPA buffer (Upstate) supplemented with
Complete protease inhibitors (Roche), 2 mM sodium orthovana-
date, and 5 mM sodium fluoride. Lysates were cleared by
centrifugation (10 minutes at 11,000 g), then prepared for
electrophoresis using LDS buffer and DTT (Invitrogen). Equal
amounts of protein were loaded per lane of a 4–12% Bis-Tris
NuPAGE gel and then separated according to the manufacturer’s
recommended protocol (Invitrogen). After transferring the protein
to nitrocellulose membranes, non-specific binding was blocked
using 5% milk in Tris-buffered saline solution containing 0.2%
Tween-20 (TBST). Primary antibodies were incubated overnight
at 4uC in 1% BSA in TBST (Pierce). Peroxidase-conjugated
secondary antibodies were used for 1 hour at room temperature.
Peroxidase activity was detected using ECL Plus (GE Healthcare).
Antibodies and dilutions used: Phospho-FRS2, 1:1000 (Upstate);
Total FRS2, 1:1000 (Upstate); anti-rabbit-HRP, 1:10,000 (Amer-
sham). Bands were quantitated using the integrated density
function of ImageJ. Data shown are representative of three
independent experiments.
Statistics
Histopathologic (ordinal) data from the blinded microscopic
evaluation were assessed using the non-parametric chi-square test.
Nominal data were analyzed by two-tailed Student’s t-test. All
calculations were done using commercial JMP statistical software
(v. 5.0; SAS Institute, Cary, NC), and significance assigned to p-
values #0.05.
RESULTS
Targeted disruption of Sulf1
An ES cell clone with a retroviral insertion in the intron between
exons 2 and 3 of the Sulf1 gene (using the nomenclature and gene
structure information provided in Morimoto-Tomito et al.)[15] was
identified by screening a gene trap ES cell library (Fig. 1A).
Chimeric mice carrying this targeted Sulf1 allele were generated
usingstandardtechniques.UponintercrossingthefirstF1generation
of Sulf1
+/2 mice in the mixed genetic background, we observed no
deviation from expected Mendelian birth ratios (Table 1). Both male
and female homozygous mutant (Sulf1
2/2)m i c ew e r ec a p a b l eo f
generating offspring, indicating no obvious fertility defect (data not
shown). Similar viability and fertility results were obtained with
Sulf1
2/2 mice after backcrossing the mutant allele 5 times onto the
C57BL/6N strain (N5). Sulf1
2/2 mice were therefore viable and
fertile in both a mixed 129/SvEvBrd; C57BL/6 background and
a purer C57BL/6 genetic background.
As the retroviral insertion site is located in an intron upstream of
the exon containing the ATG start codon of Sulf1 (Fig. 1A), we
suspected the allele might be hypomorphic rather than null. To
confirm whether the retroviral insertion indeed resulted in a loss-
or reduction-of-function allele, we performed quantitative RT-
PCR (Q-RT-PCR) using primers designed to amplify the 39 UTR
of Sulf1. We found that the retroviral insertion resulted in a severe
hypomorphic allele in nearly all tissues examined. Whereas
heterozygous animals showed the expected ,50% decrease in Sulf1
expression, homozygotes had between 0.2% and 1.7% of Sulf1
mRNA levels relative to wild-type control tissues (Fig. 1C). In-
terestingly, we observed no substantial decrease in expression of the
Sulf1 message in RNA derived from the testis (Fig. 1C). It has been
shown previously that testis tissue produces a truncated Sulf1
transcript [23], consistent with the use of an alternative promoter
that might be unaffected by the presence of the genetrap retroviral
insertion. Finally, we did not observe any significant change in Sulf2
expression in the tissues derived from the Sulf1
2/2 mice (Fig. 1D).
The hypomorphic nature of the Sulf1
2 allele was further verified
by immunohistochemistry. Sections of wild-type (WT) and Sulf1
2/2
embryonic tissue were stained with a Sulf1-specific rabbit polyclonal
antibody. Compared to WT embryos, Sulf1
2/2 embryos exhibited
a profound loss of expression of the Sulf1 protein in the floor plate of
theneuraltube,aparticularlyprominentsiteofSulf1expression(Fig.
S1). Along with the quantitative RT-PCR results (Fig. 1C), these
data confirm that the Sulf1 genetrap allele is a severe hypomorph, at
the mRNA and protein level.
Embryonic and adult Sulf1 expression
We assessed the expression of Sulf1 during development by in situ
hybridization (ISH) in whole mounts and tissue sections of
embryos from stages E9.5 to E12.5 (Fig. S2 and data not shown).
Reminiscent of the expression pattern of the rat Sulf1 homolog
(also known as RSulfFP1)[24], we detected mouse Sulf1 expression
in the floor plate of the midbrain, hindbrain, and neural tube, the
choroid plexus, the clefts of the branchial arches, dorsal telenceph-
alon,somites,eyes,palate,tongue,nasalpits,theforelimbarmgirdle,
and the condensing mesenchyme in the distal limb buds (Fig. S2).
ISH on sagittal sections of E15 embryos and E17 fetuses revealed
continued expression in the choroid plexus and the cartilaginous
anlagen of the digits, as well as scattered expression in the lungs,
gastrointestinal tract, brown adipose tissue, salivary gland, and the
esophageal lining (data not shown).
Section-based ISH of a panel of adult tissues revealed
expression in the photoreceptor layer of the retina, the Harderian
gland, blood vessels and some tubules in kidney, blood vessels in
the lungs, submucosa of the stomach, and intestinal mucosal
epithelium (data not shown). Microarray analysis of an extensive
panel of normal adult mouse tissues revealed detectable expression
of Sulf1 in nearly all sites examined, with uterus, bladder,
mesenteric lymph nodes, prostate, esophagus, lung, mammary
gland, and bone showing particularly strong expression (Fig. S3).
Targeted disruption of Sulf2
From a random insertion ES cell library, a clone was isolated with
an insertion between exon 2 (which contains the ATG start codon)
and exon 3 of the Sulf2 gene (Fig. 1B). Heterozygous chimeric mice
were isolated and bred to generate Sulf2 mutant animals. In
contrast to a recently published report [19], we observed no
deviation from the expected Mendelian birth ratios of homozygous
mutant animals, neither in the original mixed 129/SvEvBrd;
C57BL/6 background nor in mice at the N4 generation of
backcrossing into the C57BL/6N strain (Table 1). We also
observed that Sulf2
2/2 males and females were fertile (data not
shown), indicating that Sulf2 is not necessary for reproduction.
We verified that the retroviral insertion into the Sulf2 locus also
resulted in a hypomorphic allele by Q-RT-PCR. Similar to our
results in the Sulf1-disrupted mice, we found ,50% reduction in
Sulf2 mRNA levels in tissues derived from Sulf2 heterozygotes but
a marked decrease (0.9–9.1% of WT levels, depending on the
tissue examined) in Sulf2 expression in tissue from Sulf2
2/2
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PLoS ONE | www.plosone.org 4 June 2007 | Issue 6 | e575Figure 1. Sulf1 and Sulf2 gene trap alleles are hypomorphic. (A) Sulf1 retroviral insertion gene trap allele. The VICTR48 retrovirus inserted into
position 12,733,618 of chromosome 1 (February 2006 (mm8) assembly of the mouse genome, UCSC Genome Browser), which corresponds to intron 2
of Sulf1. Primers a, b, and c correspond to Sulf1-F, Sulf1-R1, and LTR, respectively, and were used to genotype the mice. Primers d and e in the 39
untranslated region refer to Sulf1-4535F and Sulf1-4611R, which were used for Q-RT-PCR amplification of the Sulf1 transcript. The position of the open
reading frame is indicated by the taller boxes; the untranslated region is represented by the shorter boxes. Not to scale. (B) Sulf2 retroviral gene trap
allele. The VICTR37 retrovirus inserted into position 165,818,084 of chromosome 2, which is intron 1 of Sulf2. Primers a, b, and c correspond to Sulf2-
F2, Sulf2-R, and LTR2, respectively, and were used to genotype the mice. Primers d and e in the 39 untranslated region refer to Sulf2-3364F and Sulf2-
3428R, which were used for Q-RT-PCR amplification of the Sulf2 transcript. (C and D) Q-RT-PCR analysis of Sulf1 (C) and Sulf2 (D) in tissues from mice
with different Sulf1 genotypes (white bars, Sulf1
+/+; grey bars, Sulf1
+/-; black bars, Sulf1
-/-). The Cycle to Threshold (Ct) values for duplicate or triplicate
samples were averaged. Each bar represents a single animal. After normalization to GAPDH or RPL19, relative Sulf1 expression levels (compared to an
average of the two WT littermate controls analyzed) were calculated based upon the 2
-DDCt method [21]. MG refers to mammary gland. (E and F) Q-
RT-PCR analysis of Sulf1 (E) and Sulf2 (F) expression in tissues from Sulf2
+/+, Sulf2
+/-,o rSulf2
-/- adult mice. Analysis was done as described above for the
Sulf1 mice. Abbreviation used: MG refers to mammary gland tissue.
doi:10.1371/journal.pone.0000575.g001
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change of Sulf1 expression in Sulf2 mutants (Fig. 1E).
Embryonic and adult Sulf2 expression
The retroviralgenetrapcassette usedtodisruptSulf2containedab-
galactosidase reporter, which we used to assess the Sulf2 expression
pattern during development. When detecting b-galactosidase
activity in a litter of embryos from a Sulf2
+/2 intercross, the
intensity of staining corresponded to the genotype status as
determined by PCR of genomic DNA (Fig. S4). Sulf2 is expressed
in a dynamic pattern at all developmental stages tested (E10.5–
E12.5; Figs. S4 and S5). Sectioning the stained embryos, we
detected b-galactosidase activity in the floor plate of the hindbrain,
floorplate and ventral progenitor region of the neural tube, choroid
plexus, roof plate of the forebrain and midbrain, the developing
retina, mesenchyme of the head and branchial arches, dorsal root
ganglia, somites (dermomyotome), forelimb buds (in a posterior-to-
anterior gradient), hindlimbs (more uniform intensity), the caudal
notochord, and the right ventricle of the heart (data not shown).
ISH of transverse sections through the forelimb level of E11.5–
E12.5 embryos confirmed the veracity of the b-galactosidase
staining, but also revealed additional expression in the condensing
sclerotome ventral to the neural tube; mesenchyme surrounding
the dorsal aorta, sinus venosus, and left common cardinal vein; the
lining of the esophagus; mesenchymal cells surrounding the
bronchi in the lung buds; palate and tongue; and condensing
mesenchyme surrounding the presumptive digits in the distal
limbuds (Fig. S4).
We also detected b-galactosidase activity by gross observation in
a panel ofnormaltissues from an adultSulf2
2/2animal.Activitywas
undetectable in muscle and spleen. Limited expression was detected
in the lung (limited to the cells lining the large bronchial airways),
stomach (cells on serosa of stomach, particularly in the pyloric
region), and uterus (subset of cells in both the myometrium and
endometrium). Abundant activity was also revealed in the ovary and
testis (data not shown). Consultation of a recently published
microarray analysis of an extensive panel of normal mouse tissues
[25] revealed detectable expression of Sulf2 in a wide variety of
tissues examined, with ovary, umbilical cord, uterus, adipose,
bladder, and intestine showing particularly strong expression (Fig.
S5).Sulf2wasalsoexpressedinavarietyofbrainstructures,including
the hippocampus, cerebral cortex, and hypothalamus (Fig. S5).
Absence of major abnormality in Sulf1
2/2 or
Sulf2
2/2 mice
Neither Sulf1
2/2 nor Sulf2
2/2 mice had any defect in long-term
survival, with both males and females living to .1.5 years of age.
As described above and previously, Sulf1 and Sulf2 are expressed in
a variety of embryonic and adult tissues (Fig. 1; Figs. S1, S2, S3,
S4, S5)[19,24,26]. We therefore cast a wide net in searching for
phenotype(s) in the Sulf1
2/2 and Sulf2
2/2 mice. We observed no
gross differences in appearance or behavior between wild-type,
heterozygous and single mutant mice. Aged adult mice were
subjected to necropsy, at which time we performed gross and
histological analysis on a subset of organs, including lung, liver,
stomach, small intestine, colon, brain, eye, spleen, kidney, and
heart. Apart from common age-related changes, which were
observed in both control and sulfatase-deficient animals, no
notable gross or histological changes were found in the single
mutants (data not shown). We conclude that neither the Sulf1- nor
the Sulf2-deficient animals exhibited any obvious gross or
histological abnormalities.
Whereas Sulf1
2/2 animals had normal body weights from birth
to adulthood (Fig. 2), we did observe a slight decrease in body
weight in 16–18 month-old Sulf2
2/2 females (in the 129SvEvBrd;
C57BL/6 mixed background), with control animals weighing
39.663.7 g (n=4, mean6SEM) and Sulf2
2/2 females weighing
24.661.6 (38% decrease; n=3,p=0.02 by two-tailed Student’s t-
test). In this same cohort of aged mice, however, the Sulf2
2/2
males (34.262.7 g, n=5) had indistinguishable weights from their
littermate controls (36.160.5 g, n=3; p<0.6 by t-test). A larger
cohort of younger Sulf2
2/2 male mice, age ,14–15 weeks,
showed a statistically significant reduction in body weight (Fig. 2D),
with control animals weighing 29.360.6 g (n=26) and Sulf2
2/2
animals weighing 23.360.8 g (20% decrease, n=8;p,0.0001 by t-
test). Notably, when Sulf2
2/2 adult mice did exhibit decreased
body weight, all organs examined except the kidneys showed
a proportional decrease in weight (Fig. 2 and data not shown). In
summary, although Sulf2
2/2 adults had decreased body weight,
they appeared grossly, histologically, and behaviorally normal.
Sulf1
2/2 Sulf2
2/2 double-knockout mice show
perinatal lethality
Given that the single mutant mice exhibited very mild or no
phenotype, we postulated that the two secreted sulfatases perform
redundant function(s) in vivo. To examine this hypothesis, we
crossed the Sulf1 and Sulf2 mutant mice to generate compound
heterozygotes. Sulf1
+/2 Sulf2
+/2 siblingswere thenintercrossed,with
the expectation that 1/16
th of their offspring would have the Sulf1
2/
2 Sulf2
2/2 genotype. Interestingly, genotyping at postnatal day
9.463.7 (mean6SD), we observed only ,18% of the expected
number of double mutants (11 expected, 2 observed; Table 2). This
reduction in viability demonstrates that the two secreted sulfatases
perform redundant and essential function(s) in vivo.
We sought to determine at what stage (embryonic or post-natal)
the double mutants were perishing. We first intercrossed Sulf1
+/2
Sulf2
2/2 and Sulf1
2/2 Sulf2
+/2 mice and isolated embryos at
E18.5, which was typically the day of birth in this strain. At E18.5,
Table 1. Sulf1
2/2 and Sulf2
2/2 mice are present at Mendelian frequencies.
..................................................................................................................................................
Parental Genotype Offspring Genotype x
2 df p
Observed (%) Expected
+/++ /22 /2 +/++ /22 /2
Sulf1 (N5) +/26+/2 86 (27) 168 (53) 65 (20) 79.75 159.5 79.75 3.67 2 NS
Sulf2 (N0) +/26+/2 11 (23) 21 (44) 16 (33) 12 24 12 2.25 2 NS
Sulf2 (N4) +/26+/2 43 (30) 65 (46) 33 (23) 35.25 70.5 35.25 1.79 2 NS
NS means not significant (p.0.05).
doi:10.1371/journal.pone.0000575.t001
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PLoS ONE | www.plosone.org 6 June 2007 | Issue 6 | e575Figure 2. Sulf1
-/- Sulf2
-/- mice have decreased body and kidney weights at birth and (for the few that survive) as adults. (A) Representative image of
Sulf1
-/- Sulf2
-/- and littermate control E18.5 day embryos just after birth, but prior to feeding. Note the pink skin-tone and apparently normal
vascularization and circulation. (B) Quantification of embryo weight (mean6SEM) at E18.5. Sulf1
-/- Sulf2
-/- embryos show a 19% decrease in weight. These
embryos also have a 12% decreased crown-rump length (data not shown). Number of embryos analyzed were as follows: Control (pooled
+/+;
+/+,
+/-;
+/+,
+/
+;
+/-,a n d
+/-;
+/- embryos), n=31;Sulf1
+/- Sulf2
-/-, n=32;Sulf1
-/- Sulf2
+/-, n=26, and Sulf1
-/- Sulf2
-/-, n=24. (C) Representative image of a typical small Sulf1
-/-
Sulf2
-/- 10-week-old male and a control littermate. Note the proportionate small stature and the lack of gross morphological differences. (D) Body weights
(mean6SEM)of15-week-oldmales.WeightsofSulf2
-/-andSulf1
-/-Sulf2
-/-micewere,20%and,30%smaller,respectively,thancontrols.Numberofadult
males analyzed were as follows: Controls (Sulf1
+/- Sulf2
+/-), n=26;Sulf1
+/- Sulf2
-/-, n=8;Sulf1
-/- Sulf2
+/-, n=10,andSulf1
-/- Sulf2
-/-, n=5. (E, F, G) Kidneys of
Sulf1
-/- Sulf2
-/- mice weresmallat E18.5 (E) andremaindisproportionatelysmall (mean6SEM)intoadulthood (F,G).TheSulf2
-/- mutantsalsohad kidneysof
decreasedsize,though the degree ofreductionwas more proportionaltothese animals’decreasein body weight. Theweightsof15-week-oldadult male
kidneys are represented as a percentage of total body weight in panel G. The kidneys analyzed here are from the same cohort of animals whose body
weights were presented in panel D. Statistical significance was evaluated using a two-tailed Student’s t-test; *, p,0.05. ***, p,0.001.
doi:10.1371/journal.pone.0000575.g002
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PLoS ONE | www.plosone.org 7 June 2007 | Issue 6 | e575we observed as many double-mutant embryos as would have been
predicted by Mendelian inheritance (,25%, Table 2). The Sulf1
2/2
Sulf2
2/2 offspring, however, had a statistically significant ,19%
decrease in body weight and a ,12% decrease in crown-rump
length (Fig. 2B and data not shown). Neither Sulf1
2/2 Sulf2
+/2 nor
Sulf1
+/2 Sulf2
2/2 single mutants showed any deviation in birth
weight from control littermates, thus providing direct evidence for
a redundant role for the sulfatases during embryonic development.
Although the Sulf1
2/2 Sulf2
2/2 embryos were smaller than control
littermates, there were no obvious gross changes in morphology.
Overt development of the limbs (including digits), head (including
palate), tail, and torso all appeared normal. Similar observations of
apparently normally developing Sulf1
2/2 Sulf2
2/2 embryos were
also made in multiple litters at E10.5, E11.5, E12.5, E13.5, and
E15.5. A thorough histological examination of sectioned E15.5
embryos revealed no divergence of Sulf1
2/2 Sulf2
2/2 from control
embryos (data not shown). This indicates that embryonic defects in
the double mutants arise late in development.
Dissection of E18.5 double mutant embryos showed that all
major organs were present and, apart from a slight decrease in size
of most organs, appeared normal morphologically. The one clear
exception were the kidneys from double mutant neonates, which
were decreased in volume by ,45% relative to kidneys from
Sulf1
+/2 Sulf2
+/2 control littermates (Fig. 2E). The small kidneys
of the Sulf1
2/2 Sulf2
2/2 embryos were either normal histologi-
cally or, in a few cases, had a modest decrease in the thicknesses of
cortex and medulla (compare Fig. 3A with 3B and 3C). All other
internal organs examined appeared histologically normal (data not
shown).
We then observed the neonates shortly after birth to determine
a potential cause of death. Genotyping at postnatal day 1–2, we
saw approximately a 50% reduction in expected viability between
birth and P1-P2 (Table 2). Of 16 double mutant neonates
genotyped at P1-P3, 7 (44%) died before weaning, with most of
those dying within the first week of life (data not shown). Of 17
double mutants that survived to weaning, 4 (24%) died within
10 days of weaning. In summary, we observed full viability of
Sulf1
2/2 Sulf2
2/2 double mutants at E18.5, ,48% survival at
P1-P2, and approximately 18% survival at weaning (Table 4), with
roughly a quarter of those pups that survive to weaning dying
shortly thereafter (two due to severe malocclusion, others for
unknown reasons). The long-term survival frequency of Sulf1
2/2
Sulf2
2/2 mice is therefore ,15%.
Consistent with the observed low birth weight, those double
mutants surviving to P1-2 showed ,25% reduction in body weight
(data not shown). Although the Sulf1
2/2 Sulf2
2/2 neonates had
a suitable skin color (pink, indicating sufficient oxygenation) and
apparently normal motility, they frequently did not have milk in
their stomachs, suggesting that the cause of early neonatal death
may have been related to undernourishment or dehydration.
Histological analysis of placenta, kidney, stomach, intestine,
pancreas, liver, and heart from double mutant neonates revealed
no obvious abnormalities explaining the inability to suckle (data
not shown). Thus, the cause of neonatal mortality remains
undetermined. However, a likely premise is that double knockout
neonates had neurological problems (suggested by the extensive
Sulf1 and Sulf2 gene expression patterns in the embryonic central
nervous system). More thorough neuroanatomic and neurobeha-
vioral assays are ongoing to further investigate the cause of
neonatal lethality.
Surviving Sulf1
2/2 Sulf2
2/2 adults are small, exhibit
subtle skeletal and renal defects, but are otherwise
normal in gross and histological structure
We were able to analyze a total of 10 adult (5 male and 5 female)
Sulf1
2/2 Sulf2
2/2 animals. All animals showed below-average
weight, with one representative cohort of ,14–15 week-old double
mutant males (n=5) having an average weight 26% less than age-
matched littermate control males (n=10) (Fig. 2D). Another cohort
of three Sulf1
2/2 Sulf2
2/2 and two control females (matched at
11 weeks of age) alsoexhibited a decreased bodyweight,withdouble
mutants weighing 29% less than controls (13.8 gv s .1 9 . 5 g,
respectively; data not shown).
We collected and weighed a full panel of organs from the adult
Sulf1
2/2 Sulf2
2/2 and control mice. When corrected for the
aforementioned decrease in body weight, all the organs appeared
to be of generally normal size and gross appearance except for the
kidneys, which were disproportionately small. For instance, in the
male cohort described above, the kidneys of double mutant
animals showed a 44% decrease in weight relative to controls
(Fig. 2F), which is substantially greater than the 26% discrepancy
Table 2. Sulf1
2/2 Sulf2
2/2 mice exhibit neonatal lethality.
..................................................................................................................................................
Parental Genotypes
1 Offspring Genotypes x
2 df p
Observed Expected
Sulf2
Sulf1
+/++ /22 /2 +/++ /22 /2
Sulf1
+/2 Sulf2
+/26Sulf1
+/2 Sulf2
+/2(P9-P10) +/+ 9 33 11 11.125 22.25 11.125 15.865 8 ,0.05
+/2 18 49 18 22.25 44.5 22.25
2/2 12 26 2 11.125 22.25 11.125
Sulf1
+/2 Sulf2
2/26Sulf1
2/2 Sulf2
+/2 (P1-P2) +/2 31 23 23 23 9.739 3 ,0.025
2/2 27 11 23 23
Sulf1
+/2 Sulf2
2/26Sulf1
2/2 Sulf2
+/2 (E17.5-E18.5) +/2 18 20 20.25 20.25 1.617 3 NS
2/2 25 18 20.25 20.25
Sulf1
+/2 Sulf2
2/26Sulf1
2/2 Sulf2
+/2(E10.5-E13.5) +/2 14 19 16.25 16.25 0.908 3 NS
2/2 17 15 16.25 16.25
1Day of genotyping is indicated in parentheses.
doi:10.1371/journal.pone.0000575.t002
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PLoS ONE | www.plosone.org 8 June 2007 | Issue 6 | e575in total body weight. Despite the decreased kidney size, renal
function did not appear to be altered in the double mutants, with
normal levels of serum and urine markers testing kidney function
(data not shown). This is consistent with the observation that the
kidneys of double mutant adults were histologically normal (data
not shown).
Whereas the Sulf1
2/2 single mutant mice were similar in body
and kidney weight to age-matched control adult males, Sulf2
2/2
mice, like the Sulf1; Sulf2 double mutants, had decreased body
weight (20% decrease) and kidney weight (29% decrease). The
degree of decrease in relative kidney and body weight was less in
the Sulf2 single mutants than in the Sulf1; Sulf2 double mutants,
indicating that although Sulf2 appears to be the more important of
the two sulfatase genes in regulating kidney development, Sulf1
also contributes to kidney growth. Therefore, Sulf1 and Sulf2
appear to play redundant roles in the regulation of body and
kidney weight.
Histological analysis of a panel of organs collected from the
adult double mutant animals revealed all tissues examined to be
histologically normal, with two exceptions. First, one 11-week-old
double mutant female had interstitial pneumonia with syncytial
cell formation localized to the peribronchiolar region, suggesting
the possibility of a latent phenotype related to immunological
dysfunction. A survey of immunological cell types in the peripheral
blood and spleen showed no obvious defect in immune cell
development of the double mutant adults (data not shown).
However, more specific analyses might yet reveal a role of
the sulfatases in immune function. Second, all of the Sulf1
2/2
Sulf2
2/2 adults examined showed retention of cartilage cores in
the cortical bone of the tibial metaphysis, sometimes in
conjunction with trabecular disorganization (compare Fig. 3N
with 3O and 3P). In summary, surviving Sulf1
2/2 Sulf2
2/2 adults
are small in stature, but show apparently normal behavior and
have grossly and histologically normal tissues, with the lone
exception of the subtle changes observed in the bones.
Sulf1
2/2 Sulf2
2/2 embryos show defects in bone
development
Given our observation of a bone defect in the Sulf1
2/2 Sulf2
2/2
adults (Fig. 3O, P) and the expression of Sulf1 and Sulf2 at several
sites in bone during embryogenesis (Fig. S2 and S4 and data not
shown), we analyzed bone development in the Sulf1
2/2 Sulf2
2/2
embryos. To this end, we stained dehydrated E18.5 embryos with
alcian blue and alizarin red to assess bone and cartilage formation.
In general, the skeletons of double mutants were similar to those of
control littermates, though notably smaller in stature (Fig. 4A, B).
One highly penetrant difference (12 of 14 (86%) Sulf1
2/2 Sulf2
2/2
E18.5 embryos examined) was the asymmetry and/or fusion of
sternebrae (Fig. 4E–H, Table 4). Only 1 of 19 (,5%) control
Figure 3. The Sulf1
-/- Sulf2
-/- mice have multiple subtle anatomic
anomalies, including kidney hypoplasia and skeletal defects. (A–C) At
E18.5, double knockout fetuses have small kidneys in sagittal sections,
and some have attenuated cortices and medullae. (D–G) Sagittal
sections of the distal forelimb from E15.5 embryos revealed altered
cartilage zonation in the ulna (D, E) and radius (F, G) bones. Yellow lines
indicate the transition from distal/low proliferating (above line) to high
proliferating (below line) chondrocyte populations as assessed by
cellular morphology. (H, I) Sagittal section of the skull base of E18.5
embryos demonstrating abnormal fusion at the cartilaginous interface
between the basisphenoid (bs) and basioccipital (bo) bones. (J–M)
Coronal section (at the midbrain level) of the skull base at E18.5
showing abnormal midline fusion of the basisphenoid (bs) bone in the
double mutant embryos. Bones depicted in panels K, L, and M were
from three separate Sulf1
2/2 Sulf2
2/2 embryos. Occasionally the
r
pituitary gland descended into the gap at the midline of Sulf1
2/2
Sulf2
2/2 embryos (as indicated by the arrow in panel L). (N–P)
Representative sections through the proximal tibia of adult females.
Arrows indicate regions of retained cartilage in regions that normally
consist only of ossified bone. Representative control animals had the
Sulf1
+/2 Sulf2
+/2 genotype in panels A, D, F, H, and N, and the Sulf1
+/2
Sulf2
2/2 genotype in panel J. Representative Sulf1
2/2 Sulf2
2/2 double
mutant animals are shown in panels B, C, E, G, I, K, L, M, O, and P.
Abbreviations used: bo, basioccipital; bs, basisphenoid; p, pituitary
gland. The scale bar in (A) represents 500 mm in panels A–C; the scale
bar in (H) represents 500 mm in panels H–M; the scale bar in (N)
represents 500 mm in panels N–P.
doi:10.1371/journal.pone.0000575.g003
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PLoS ONE | www.plosone.org 9 June 2007 | Issue 6 | e575embryos showed this anomaly. High penetrance of this defect
required both Sulf1 and Sulf2 deficiency, in that only one of five
Sulf1
2/2 and none of three Sulf2
2/2 embryos exhibited sternebral
defects (data not shown).
Histological examination of E18.5 embryos focusing on skeletal
development revealed two other subtle but highly penetrant
alterations in Sulf1- and Sulf2-deficient embryos. These changes
included (i) non-fusion of the posterior basisphenoid bone
(Figs. 3K, L, and M; Fig. 4D; Table 4), in one case with the
pituitary gland extending ventrally into the gap (arrow, Fig. 4L);
and (ii) aberrant fusion of the basioccipital and basisphenoid bones
indicated by widening and bulging of the cartilage interface
between these two bones (Fig. 3I, Table 4). The increased
prevalence of each of these lesions in Sulf1
2/2 Sulf2
2/2 embryos
as compared to control embryos was statistically significant
(p,0.02 by Chi square method) using blinded analysis or, when
appropriate, direct slide-by-slide comparison.
Seeking a more quantitative analysis of the skeletal phenotype of
the Sulf1
2/2 Sulf2
2/2 embryos, we analyzed E18.5 embryonic
skeletons by micro-computed tomography (mCT). Assessing the
ossified bone volume of several different bones in the skeleton, we
found that the double mutants exhibited a decrease in bone
volume (Tables 3 and 4) and length (data not shown) of the
humerus and femur. Likewise, the interparietal, basisphenoid,
basioccipital, and supraoccipital bones of the skull also had
decreased volumes (usually ,15% smaller than bones from control
embryos, Table 3), though the decreased volume of the
supraoccipital bone was observed with only 50% penetrance (4
of 8 embryos analyzed had a mean volume of less than 2 SD below
the mean of age-matched controls). In contrast, the volume of the
frontal and parietal bones of the skull showed no difference between
double mutants and controls. In summary, all bones examined
except the frontal and parietal bones of the skull were ,15–20%
smaller in the Sulf1
2/2 Sulf2
2/2 embryos as compared to Sulf1
+/2
Sulf2
+/2 littermate controls (Table 3). Interestingly, none of the
bones from Sulf1
2/2 Sulf2
2/2 embryos showed a change in average
bone density as compared to control littermates (data not shown),
indicating that the ossified regions of the double mutant embryos’
bones were smaller but not less dense.
Seeking an explanation for the shorter long bones with
decreased volume, we assessed the bones of E15.5 embryos.
Sulf1
2/2 Sulf2
2/2 embryos showed slightly shorter long bones in
all limbs. All expected chondrocyte cell populations (distal,
proliferative, and hypertrophic) appeared to be present (Fig. 3D–
G). Overt chondrocyte differentiation was not altered, in that we
observed normal expression patterns of Collagen II and Collagen X
(Fig. S6). One apparent defect in the double mutants was a smaller
distal (low proliferating) chondrocyte population (compare panels
D with E and F with G in Fig. 3). In contrast, both the proliferative
and hypertrophic chondrocyte populations appeared to be present
in comparable numbers.
Sulf1
2/2 Sulf2
2/2 cells are hyper-responsive to
fibroblast growth factors (FGF)
Previous work has shown that the sulfation status of heparan
sulfate is important for its promotion of FGF signaling [27–29].
Over-expression of Sulf1 in tumor cell lines acts to inhibit FGF-
dependent signaling [23]. Furthermore, transgenic mice engi-
Figure 4. Embryos deficient for both Sulf1 and Sulf2 had several
distinct defects in bone development. (A–F) Representative images of
E18.5 littermate control Sulf1
+/2 Sulf2
+/2 (A, C, E, G) and Sulf1
2/2 Sulf2
2/
2 (B, D, F, H) fetuses double-stained with alcian blue and alizarin red to
demonstrate skeletal elements. (A, B) Whole-mount images demon-
strating the reduced size of the double mutant skeleton. All bones are
present, and no obvious fusion defects are apparent in any class of
joints. (C, D) Skulls viewed from the posterior side. Note the hole in the
dorsal side of the basisphenoid bone of the Sulf1
-/2 Sulf2
2/2 skeleton
(to the right in D). Also note that the palate appears to be developing
properly. (E–H) Rib cages (skeletal double staining; E, F) and sternums
(thresholded mCT; G,H) revealing sternebral asymmetry about the
midline in double knockout mice (black arrowheads in F, and yellow
arrowhead in H). The 4
th and 5
th sternebrae (counting from rostral to
caudal) have a slender site of ossification bridging them at the midline
(F, with another example in panel H [yellow arrow]). Scale bars in panels
B, D, F, and G represent 1 mm for panels A/B, C/D, E/F, and G/H,
respectively.
doi:10.1371/journal.pone.0000575.g004
Table 3. Selected bones of Sulf1
2/2 Sulf2
2/2 embryos show decreased volume.
..................................................................................................................................................
Humerus Femur Frontal Parietal Interparietal Supraoccipital Basioccipital Basisphenoid
Control 0.59560.032 0.43160.037 0.51260.017 0.27360.007 0.17160.004 0.20160.013 0.39660.015 0.29560.008
Double Mutant 0.46860.015 0.36460.010 0.47760.013 0.26360.007 0.14560.008 0.15660.017 0.33560.010 0.25560.008
% decrease 21.4 15.7 6.8 3.7 15.3 22.6 15.5 13.6
p 0.002 0.041 0.152 0.364 0.042 0.114 0.007 0.008
mCT images of E18.5 embryos were thresholded to visualize only mineralized bone. Volumes are expressed in mm
3 units and are shown as a mean6SEM. The volumes
of the left and right humerus, femur, frontal, and parietal bones were averaged to obtain a value for each embryo. Control embryos (n=4) had the Sulf1
+/2 Sulf2
+/2
genotype. Double mutant embryos (n=8) had the Sulf1
2/2 Sulf2
2/2 genotype. Statistical significance was assessed using a two-tailed Student’s t-test.
doi:10.1371/journal.pone.0000575.t003
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PLoS ONE | www.plosone.org 10 June 2007 | Issue 6 | e575neered to express a hyperactive mutant allele of FGFR1 [30] or
FGFR3 [31] in bone results in sternal fusion, a phenotype we
observed in our sulfatase-deficient embryos.
We therefore sought to assess the FGF sensitivity of cells from
Sulf1
2/2 Sulf2
2/2 embryos. To accomplish this, we derived
fibroblast cell cultures from embryos and assessed their responsive-
ness to different doses of FGF1 and FGF2, using phosphorylation of
theFGFRsignalingadaptorFRS2asamarkerofpathwayactivation
[32]. Whereas Sulf1
2/2 Sulf2
2/2 and Sulf1
+/2 Sulf2
+/2 control
MEFs showed similar kinetics of FRS2 phosphorylation when
assessed at a saturating concentration of FGF1 and FGF2 (data not
shown), sulfatase-deficient MEFs were hyper-sensitive to both FGF1
and FGF2, activating half-maximal FRS2 phosphorylation at ,5-
fold lower concentration of FGFs (Fig. 5). This demonstrates that the
secreted sulfatases are involved with modulation of FGF signaling
and suggests a potential mechanism for the observed sternal fusion
phenotype.
DISCUSSION
Sulf1 and Sulf2 perform redundant and essential
functions during embryonic and neonatal
development
We describe here the phenotype of mice engineered to contain
retroviral gene trap alleles inserted into the Sulf1 and/or Sulf2 loci.
We showed that the Sulf1 and Sulf2 gene trap alleles are
profoundly hypomorphic, with no compensatory changes in
paralog gene expression (Fig. 1). Mice deficient for either Sulf1
or Sulf2 alone were viable, fertile, and normal by nearly all criteria
examined (Table 1, Fig. 2). Sulf2-deficient adult mice did show
a tendency towards decreased body weight relative to control
animals, but this tendency was not accompanied by any obvious
functional or structural changes. In contrast to a recent report
[19], we observed no deviation from the expected Mendelian birth
ratios of homozygous Sulf2 mutant animals, either in our original
mixed 129/SvEvBrd; C57BL/6 background or in mice at the N4
generation of backcrossing into the C57BL/6N strain (Table 1).
We also did not observe the previously described runting or lung
defects (Fig. 2 and data not shown)[19]. Perhaps the discrepancies
between our results and those of Lum et al. [19] were due to the
difference in the 129 genetic strain background used (129/
SvEvBrd in this study vs. 129P2/Ola in Lum et al.): the previously-
reported reduction in decreased Sulf2
2/2 viability was only seen in
the 129P2/Ola; C57BL/6 mixed background and not in two
other more homogeneous backgrounds (C57BL/6 [N3 and N7]
and FVB/N [N1 and N7]). Alternatively, the degree of hypomor-
phism and/or the nature of any aberrant transcripts generated by
the different gene trap alleles used in our and the previous study
might have affected the phenotypic outcome. In either case, the
effect(s) of Sulf2 deficiency are clearly quite subtle.
We also showed that, as remarked upon briefly by Lamanna et
al. [17,18], Sulf1 and Sulf2 are functionally redundant genes
essential for viability. We report here the first characterization of
the penetrance and timing of perinatal lethality in mice deficient
for Sulf1 and Sulf2, as well as the phenotype of the double mutant
embryos and neonates. Though Sulf1 and Sulf2 are expressed in
a wide variety of embryonic and adult tissues (Fig. 1; Figs. S1, S2,
S3, S4, S5), the development of secreted sulfatase-deficient
mice proceeds with remarkably normal integrity, with the sole
developmental alterations observed to be decreased body size
accompanied by subtle kidney and bone defects. The functions of
the secreted sulfatases, though obviously important as evidenced
by the neonatal lethality in their absence, are likely to be
understated, perhaps via refining or restricting the extent of some
other essential signaling pathways.
The bone defects observed in the Sulf1
2/2 Sulf2
2/2 embryos
are remarkable in several ways. First, there does appear to be
a deficit in bone growth in the double mutants, in that bones
located in both the axial and appendicular skeleton, which form by
the distinct processes of endochondral and intramembranous
ossification, showed a decrease in ossified bone volume (Tables 3
and 4). Second, although the secreted sulfatase-deficient skeletons
appeared overall to be patterned normally (Fig. 4A and B), we did
observe several highly specific morphological defects at the
midline, including sternal fusion and defective basisphenoid
patterning. Interestingly, sternal defects such as those exhibited
by the Sulf1
2/2 Sulf2
2/2 embryos have been reported not only in
the Hs2st-deficient mice (see below), but also in mice with
compound mutations in different Bmp family members [33],
EphrinB1 mutants [34], and in a mice engineered to contain extra
copies of a hypermorphic Fgfr1 allele or transgenic expression of
hypermorphic Fgfr3 allele [30,31]. Perhaps this convergence in
phenotypes indicates a role for the secreted sulfatases in the
regulation of Bmp, Fgf, and/or Ephrin signaling during sternal
development. Our demonstration that Sulf1
2/2 Sulf2
2/2 fibro-
blasts are hypersensitive to FGF signaling (Fig. 5) supports this
supposition. Third, whereas nearly all joints examined in the
Sulf1
2/2 Sulf2
2/2 double mutants appeared grossly and histolog-
ically normal (Fig. 4), two joints in the base of the skull had
Table 4. Penetrance of selected phenotypes in the Sulf1
2/2
Sulf2
2/2 animals.
......................................................................
Phenotype Age Frequency (%) n
Viability
1 E10.5-E13.5 92 65
E17.5-E18.5 89 81
P1-P2 48 92
P9-P10 18 178
Bone Morphology
2
Sternum defects E18.5 86 14
Basisphenoid defect E18.5 100 9
Aberrant BO/BS fusion E18.5 100 4
Bone volume
3
Femur E18.5 38 8
Humerus E18.5 88 8
Interparietal E18.5 75 8
Supraoccipital E18.5 75 8
Basioccipital E18.5 75 8
Basisphenoid E18.5 100 8
Kidney volume
3
Adult 14–15 w 80 5
Embryo E18.5 100 3
Refer to text for complete description of phenotypes observed. Abbreviations
used: BO, basioccipital; BS, basisphenoid; w, weeks.
1Frequency defined as the number expected (by standard Mendelian
segregation, see Table 2) divided by the number observed; n defined as total
number of animals analyzed in a given age range
2Frequency defined as the percentage of Sulf1
2/2 Sulf2
2/2 embryos that
showed the described phenotype; n was the number of Sulf1
2/2 Sulf2
2/2
embryos analyzed
3Frequency defined as the percentage of Sulf1
2/2 Sulf2
2/2 animals whose
mean volume for the kidney or indicated bone was less than the smallest of
the control animals’ kidney or bone volumes; n as the number of Sulf1
2/2
Sulf2
2/2 animals analyzed
doi:10.1371/journal.pone.0000575.t004
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PLoS ONE | www.plosone.org 11 June 2007 | Issue 6 | e575notable, yet distinct defects (a thickening of the basioccipital/
basisphenoid suture and a failure of the posterior basisphenoid
bone to fuse at the midline). A similar basisphenoid defect has
been reported in Bmp7- and Cdon-null embryos [35,36]. This
phenocopy congruence supports the possible role of secreted
sulfatases in regulating Bmp and Hedgehog signaling. Finally, it is
worth noting several phenotypes that were not observed in the
Sulf1
2/2 Sulf2
2/2 embryos; in particular, we did not find skull
vault suture defects, cleft palate, appendicular joint fusions, or
polydactyly. All of these defects have been associated with altered
Fgf, Bmp, or Hh signaling. An interesting implication of this
discrepancy is that the sulfatases might regulate heparan sulfate-
dependent growth factor signaling at some but not all developing
bone sites. Further work will be required to confirm this possibility.
The exact cause of neonatal lethality remains unclear. Even if
the observed decrease in kidney size were to result in altered renal
function (a prediction not supported by the apparently normal
kidney function we measured in the Sulf1
2/2 Sulf2
2/2 adults that
had disproportionately small kidneys), one would not expect such
a precipitous decline in neonatal survival. The normal structure of
thoracic viscera and their branches (data not shown) suggested that
altered cardiovascular or pulmonary function–a common etiology
for perinatal mortality–was also not the cause of lethality in this
case. Likewise, the digestive organs and skeleton did not exhibit
substantive anatomic abnormalities (data not shown). The
frequent absence of milk spots in double knockout neonates
suggested that an absence or reduction in suckling, leading
ultimately to dehydration, might have been a cause of mortality in
the double mutants. A potentially deficient feeding response might
in turn be due to underlying neurological defects, as suggested by
examination of other genes expressed in the central nervous
system [37,38]. We are currently exploring this possible patho-
genesis as an explanation for the lethality observed in Sulf1
2/2
Sulf2
2/2 neonates.
The phenotype of the surviving Sulf1
2/2 Sulf2
2/2
mice is similar to that of Hs2st mutant mice
Several recent studies have revealed an unexpected compensatory
link between the 6-O and 2-O sulfation states of heparan sulfate, in
both vertebrate (mouse) and invertebrate (Drosophila) systems
[17,39,40]. Specifically, tissues from mice with a gene trap
disruption of the single 2-O-sulfotransferase (Hs2st) gene exhibit
not only the expected decrease in 2-O-sulfated iduronic acid, but
also an apparently compensatory increase in 6-O sulfation of N-
sulfoglucosamine [40]. Lamanna et al. recently reported that
embryonic fibroblasts derived from mice devoid of both the Sulf1
and Sulf2 secreted sulfatases had not only the expected increase in
6-O sulfation of glucosamine, but also a decrease in 2-O sulfated
iduronic acid [17], the same trends as reported for the Hs2st-
deficient mice.
Mice deficient for Hs2st exhibit defective skeletal development,
bilateral kidney agenesis, cleft palate, decreased cerebral cortex
thickness, polydactyly, and iris coloboma. In addition, Hs2st-
deficent mice are perinatal lethal with full penetrance [9,41]. The
Sulf1; Sulf2-deficient mice, as reported here, showed phenotypic
similarity to the Hs2st-deficient mice, albeit of lesser severity.
Specifically, both mutant strains of mice exhibited sternal fusions,
Figure 5. Sulf1
2/2 Sulf2
2/2 embryonic fibroblasts are hyper-sensitive to fibroblast growth factors. Fibroblasts were stimulated with differing
doses of FGF1 (A, B) or FGF2 (C, D) for 10 minutes, then assessed for activation of signaling by Western analysis of phosphorylated FRS2. Results are
representative of three independent experiments.
doi:10.1371/journal.pone.0000575.g005
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PLoS ONE | www.plosone.org 12 June 2007 | Issue 6 | e575defects in kidney development, and perinatal lethality, indicating
that Hs2st and the secreted sulfatases might regulate similar
developmental processes. In contrast, Sulf1
2/2 Sulf2
2/2 mice did
not show cleft palate, cerebral cortex diminution, digit duplica-
tions, or eye defects, despite the fact that Sulf1 and Sulf2 are
expressed in all of these tissues (Figs. S2 and S4 and data not
shown). The differences between the phenotypes of the two mice
might indicate (i) that the sulfatases are not expressed at the correct
time and/or place to play a role in all of the same developmental
processes as Hs2st, (ii) that the sulfation status changes of the
sulfotransferase- and sulfatase-deficient tissues differ in some way
not revealed by the previous studies, or (iii) that the effect of
deficiency of an intracellular biosynthetic enzyme, Hs2st, might be
more profound than the deficiency of secreted enzymes, Sulf1 and
Sulf2, that act ex post facto.
The subtlety of the Sulf1; Sulf2 double deficient
phenotype would not have been predicted based
upon previous in vitro experiments
Based almost entirely upon over-expression studies in cell lines
grown in vitro, the secreted sulfatases have been shown to modulate
a wide variety of heparin-binding growth factor signaling
pathways, including WNT, FGF, HB-EGF, HGF, and BMP
[16,23,42–45]. Except for the cases of WNT1 and BMP4, wherein
elevated expression of the sulfatases promotes cell signaling, the
literature is in agreement that forced (over)expression of Sulf1
strongly inhibits signaling by various heparin-binding growth
factors (including FGF2, HB-EGF, and HGF). Furthermore,
recombinant Sulf2 enzyme has been shown to release heparan
sulfate- and heparin-bound signaling proteins such as VEGF165,
FGF1, and SDF1 [46], conferring another potential set of non-cell
autonomous functions to the secreted sulfatases.
Given that most of the aforementioned signaling pathways are
critical for certain developmental processes and patterning events,
one might have predicted from the in vitro studies that secreted
sulfatase-deficient mice would have exhibited profound develop-
mental defects in a multitude of organ systems. This prediction
was not borne out by the present organismal loss-of-function study.
On the contrary, we show here that mice with disrupted Sulf1 and
Sulf2 genes are by and large normal, with a few subtle patterning
and growth defects. As evidenced by the high penetrance neonatal
lethality, clearly the secreted sulfatases are essential for some
process critical for life. Perhaps these enzymes are involved in fine-
tuning rather than directing the spatial distribution of heparan
sulfate-binding factors.
Conclusion
In summary, we have shown that the Sulf1 and Sulf2 secreted 6-O-
endosulfatase genes are redundant and essential for post-natal
survival in developing mice. Whereas animals deficient for either
Sulf1 or Sulf2 alone have normal birth weight, full viability, and
histologically normal organs, mice simultaneously deficient for
both Sulf1 and Sulf2 exhibit low birth weight, ,50% neonatal
lethality, ,80% lethality as of weaning, failure to thrive, and
a variety of skeletal and renal defects that arise during late
embryogenesis.
SUPPORTING INFORMATION
Figure S1 Loss of Sulf1 protein expression in Sulf1
2/2 embryos.
Immunohistochemistry using a Sulf1-specific affinity purified
polyclonal antibody was performed on frozen sections of WT (A,
C) or Sulf1
2/2 (B, D) embryos. Note the loss of Sulf1 expression in
the floorplates of Sulf1
2/2 embryos. Floor plate cells are outlined
in yellow to facilitate visual comparison.
Found at: doi:10.1371/journal.pone.0000575.s001 (5.07 MB TIF)
Figure S2 Sulf1 is expressed in a dynamically shifting pattern
throughout mouse embryonic development. Whole mount in situ
hybridization (ISH) using a DIG-labeled Sulf1 probe was
performed on WT embryos at ages E9.5 (A, F), E10.5 (B, G),
and E11.5 (C, H). Embryos in (F–H) are viewed from a rostral
position, with dorsal at the top. Section-based ISH using
35S-
labeled Sulf1 probe was performed on 20-mm transverse forelimb-
level sections of E10.5 (D, E), E11.5 (I–J), and E12.5 (K–N)
embryos. Abbreviations used: ao, aorta; ar, artery; b, bronchus; cp,
choroid plexus; cv, cardinal vein; e, esophagus; lb, distal forelimb
bud; n, notochord; nt, neural tube; p, palate; sc, condensing
sclerotome; t, tongue. Scale bar in (A) corresponds to 1 mm in
panels A, B, and C, and 0.67 mm in panels F, G, and H. Scale bar
in (J) represents 200 mm in panels D, E, I, J, K, L, M, and N.
Found at: doi:10.1371/journal.pone.0000575.s002 (3.64 MB TIF)
Figure S3 Sulf1 is expressed in many tissues of adult mice.
Expression of Sulf1 in tissues derived from wild-type C57BL/6
adults, as determined by microarray analysis (Gene Logic, Inc.,
Gaithersburg, MD). MAS5.0 values are shown for probeset
113914_at on the MGU74B Affymetrix chip (Affymetrix, Santa
Clara, CA). Each point refers to a different sample; the lines
represent the mean expression value for each tissue. Similar
expression patterns were also observed using probeset 116019_at
and in tissues derived from 129 and DBA strains of mice (data not
shown).
Found at: doi:10.1371/journal.pone.0000575.s003 (0.45 MB TIF)
Figure S4 Sulf2 is expressed abundantly and dynamically at many
locations in developing mouse embryos. b-Galactosidase activity
(from the VICTR37 gene trap allele inserted in the Sulf2 locus) was
detected in whole mount preparations using a standard lacZ
histochemistry method at E10.5 (A), E11.5 (B, C), and E12.5 (D,
E). (A) The degree of staining corresponds to the number of gene
trapallelesinherited,withWTanimals(upper)showingundetectable
X-gal deposition and homozygous embryos (bottom) showing more
intense staining than heterozygous embryos (middle). Sulf2
+/2 (B, C)
and Sulf2
2/2 (D, E) embryos were imaged after detection of b-
galactosidase activity. Section-based in situ hybridization using
35S-
labeled Sulf2 p r o b ew a sp e r f o r m e do n2 0 - mm transverse forelimb-
level sections of E11.5 (F–G) and E12.5 (H–K) embryos. The same
abbreviations were used as in Figure 2. Scale bar in (A) corresponds
to 1 mmin panels A, B, C, and E.The scale bar in (D) is 1 mm. The
scale bar in (G) represents 200 mm in panels F–K.
Found at: doi:10.1371/journal.pone.0000575.s004 (3.52 MB TIF)
Figure S5 Sulf2 is also expressed in numerous tissues in adult
and developing mice. Expression of Sulf2 in tissues derived from
duplicate wild-type C57BL/6 adults (upper two panels) and
embryonic samples (lower panel), as determined by consulting the
microarray analysis submitted to Gene Expression Omnibus
(GEO) with accession number GSE1133. Expression values are
shown for probeset gnflm29631_a_at on the custom Affymetrix
chip [25]. Each point refers to a different sample; the lines
represent the mean expression value for each tissue.
Found at: doi:10.1371/journal.pone.0000575.s005 (0.61 MB TIF)
Figure S6 In situ hybridization of bone differentiation markers
in sulfatase-deficient embryos. Collagen II (A, B) and Collagen X (C, D)
expression wereassessed insectionsof distalulnas ofcontrol Sulf1
+/2
Sulf2
+/2 (A, C) and Sulf1
2/2 Sulf2
2/2 (B, D) E15.5 embryos.
Found at: doi:10.1371/journal.pone.0000575.s006 (10.15 MB
TIF)
Sulf1&2: Redundant & Essential
PLoS ONE | www.plosone.org 13 June 2007 | Issue 6 | e575ACKNOWLEDGMENTS
We thank Martin Garcia and Christine Olsson for their assistance in
managing and caring for the mouse colonies. We also appreciated the
advice, protocols, and materials provided by Mark Solloway, Kim Newton,
Weilan Ye, and Hua Tian.
Author Contributions
Conceived and designed the experiments: CH AA. Performed the
experiments: CH HB BG KW SC DG. Analyzed the data: CH AA HB
BG BB DF. Contributed reagents/materials/analysis tools: MT BG KW
RC GF DG. Wrote the paper: CH AA.
REFERENCES
1. Hacker U, Nybakken K, Perrimon N (2005) Heparan sulphate proteoglycans:
the sweet side of development. Nat Rev Mol Cell Biol 6: 530–541.
2. Perrimon N, Bernfield M (2000) Specificities of heparan sulphate proteoglycans
in developmental processes. Nature 404: 725–728.
3. Lind T, Tufaro F, McCormick C, Lindahl U, Lidholt K (1998) The putative
tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the
biosynthesis of heparan sulfate. J Biol Chem 273: 26265–26268.
4. McCormick C, Leduc Y, Martindale D, Mattison K, Esford LE, et al. (1998)
The putative tumour suppressor EXT1 alters the expression of cell-surface
heparan sulfate. Nat Genet 19: 158–161.
5. Esko JD, Selleck SB (2002) Order out of chaos: assembly of ligand binding sites
in heparan sulfate. Annu Rev Biochem 71: 435–471.
6. Forsberg E, Kjellen L (2001) Heparan sulfate: lessons from knockout mice. J Clin
Invest 108: 175–180.
7. Ledin J, Staatz W, Li JP, Gotte M, Selleck S, et al. (2004) Heparan sulfate
structure in mice with genetically modified heparan sulfate production. J Biol
Chem 279: 42732–42741.
8. Lin X, Wei G, Shi Z, Dryer L, Esko JD, et al. (2000) Disruption of gastrulation
and heparan sulfate biosynthesis in EXT1-deficient mice. Dev Biol 224:
299–311.
9. Bullock SL, Fletcher JM, Beddington RS, Wilson VA (1998) Renal agenesis in
mice homozygous for a gene trap mutation in the gene encoding heparan sulfate
2-sulfotransferase. Genes Dev 12: 1894–1906.
10. Fan G, Xiao L, Cheng L, Wang X, Sun B, et al. (2000) Targeted disruption of
NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in
mice. FEBS Lett 467: 7–11.
11. Ringvall M, Ledin J, Holmborn K, van Kuppevelt T, Ellin F, et al. (2000)
Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-
deacetylase/N-sulfotransferase-1. J Biol Chem 275: 25926–25930.
12. Bink RJ, Habuchi H, Lele Z, Dolk E, Joore J, et al. (2003) Heparan sulfate 6-O-
sulfotransferase is essential for muscle development in zebrafish. J Biol Chem
278: 31118–31127.
13. Chen E, Stringer SE, Rusch MA, Selleck SB, Ekker SC (2005) A unique role for
6-O sulfation modification in zebrafish vascular development. Dev Biol 284:
364–376.
14. Dhoot GK, Gustafsson MK, Ai X, Sun W, Standiford DM, et al. (2001)
Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase.
Science 293: 1663–1666.
15. Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S, Rosen SD (2002)
Cloning and characterization of two extracellular heparin-degrading endosulfa-
tases in mice and humans. J Biol Chem 277: 49175–49185.
16. Ai X, Do AT, Lozynska O, Kusche-Gullberg M, Lindahl U, et al. (2003) QSulf1
remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to
promote Wnt signaling. J Cell Biol 162: 341–351.
17. Lamanna WC, Baldwin RJ, Padva M, Kalus I, Ten Dam G, et al. (2006)
Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-
operativity. Biochem J 400: 63–73.
18. Lamanna WC, Kalus I, Padva M, Baldwin RJ, Merry CL, et al. (2007) The
heparanome–the enigma of encoding and decoding heparan sulfate sulfation.
J Biotechnol 129: 290–307.
19. Lum DH, Tan J, Rosen SD, Werb Z (2007) Gene trap disruption of the mouse
heparan sulfate 6-O-endosulfatase gene, Sulf2. Mol Cell Biol 27: 678–688.
20. Zambrowicz BP, Friedrich GA, Buxton EC, Lilleberg SL, Person C, et al. (1998)
Disruption and sequence identification of 2,000 genes in mouse embryonic stem
cells. Nature 392: 608–611.
21. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:
402–408.
22. Solloway MJ, Dudley AT, Bikoff EK, Lyons KM, Hogan BL, et al. (1998) Mice
lacking Bmp6 function. Dev Genet 22: 321–339.
23. Lai J, Chien J, Staub J, Avula R, Greene EL, et al. (2003) Loss of HSulf-1 up-
regulates heparin-binding growth factor signaling in cancer. J Biol Chem 278:
23107–23117.
24. Ohto T, Uchida H, Yamazaki H, Keino-Masu K, Matsui A, et al. (2002)
Identification of a novel nonlysosomal sulphatase expressed in the floor plate,
choroid plexus and cartilage. Genes Cells 7: 173–185.
25. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, et al. (2004) A gene atlas of
the mouse and human protein-encoding transcriptomes. Proc Natl Acad
Sci U S A 101: 6062–6067.
26. Nagamine S, Koike S, Keino-Masu K, Masu M (2005) Expression of a heparan
sulfate remodeling enzyme, heparan sulfate 6-O-endosulfatase sulfatase FP2, in
the rat nervous system. Brain Res Dev Brain Res 159: 135–143.
27. Faham S, Hileman RE, Fromm JR, Linhardt RJ, Rees DC (1996) Heparin
structure and interactions with basic fibroblast growth factor. Science 271:
1116–1120.
28. Pellegrini L, Burke DF, von Delft F, Mulloy B, Blundell TL (2000) Crystal
structure of fibroblast growth factor receptor ectodomain bound to ligand and
heparin. Nature 407: 1029–1034.
29. Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, et al.
(2000) Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual
role for heparin in FGFR binding and dimerization. Mol Cell 6: 743–750.
30. Hajihosseini MK, Lalioti MD, Arthaud S, Burgar HR, Brown JM, et al. (2004)
Skeletal development is regulated by fibroblast growth factor receptor 1
signalling dynamics. Development 131: 325–335.
31. Wang Q, Green RP, Zhao G, Ornitz DM (2001) Differential regulation of
endochondral bone growth and joint development by FGFR1 and FGFR3
tyrosine kinase domains. Development 128: 3867–3876.
32. Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, et al.
(1997) A lipid-anchored Grb2-binding protein that links FGF-receptor activation
to the Ras/MAPK signaling pathway. Cell 89: 693–702.
33. Katagiri T, Boorla S, Frendo JL, Hogan BL, Karsenty G (1998) Skeletal
abnormalities in doubly heterozygous Bmp4 and Bmp7 mice. Dev Genet 22:
340–348.
34. Compagni A, Logan M, Klein R, Adams RH (2003) Control of skeletal
patterning by ephrinB1-EphB interactions. Dev Cell 5: 217–230.
35. Jena N, Martin-Seisdedos C, McCue P, Croce CM (1997) BMP7 null mutation
in mice: developmental defects in skeleton, kidney, and eye. Exp Cell Res 230:
28–37.
36. Cole F, Krauss RS (2003) Microform holoprosencephaly in mice that lack the Ig
superfamily member Cdon. Curr Biol 13: 411–415.
37. Yagi T, Aizawa S, Tokunaga T, Shigetani Y, Takeda N, et al. (1993) A role for
Fyn tyrosine kinase in the suckling behaviour of neonatal mice. Nature 366:
742–745.
38. DeChiara TM, Vejsada R, Poueymirou WT, Acheson A, Suri C, et al. (1995)
Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound
motor neuron deficits at birth. Cell 83: 313–322.
39. Kamimura K, Koyama T, Habuchi H, Ueda R, Masu M, et al. (2006) Specific
and flexible roles of heparan sulfate modifications in Drosophila FGF signaling.
J Cell Biol 174: 773–778.
40. Merry CL, Bullock SL, Swan DC, Backen AC, Lyon M, et al. (2001) The
molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse. J Biol
Chem 276: 35429–35434.
41. McLaughlin D, Karlsson F, Tian N, Pratt T, Bullock SL, et al. (2003) Specific
modification of heparan sulphate is required for normal cerebral cortical
development. Mech Dev 120: 1481–1488.
42. Lai JP, Chien J, Strome SE, Staub J, Montoya DP, et al. (2004) HSulf-1
modulates HGF-mediated tumor cell invasion and signaling in head and neck
squamous carcinoma. Oncogene 23: 1439–1447.
43. Lai JP, Chien JR, Moser DR, Staub JK, Aderca I, et al. (2004) hSulf1 Sulfatase
promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding
growth factor signaling. Gastroenterology 126: 231–248.
44. Viviano BL, Paine-Saunders S, Gasiunas N, Gallagher J, Saunders S (2004)
Domain-specific modification of heparan sulfate by Qsulf1 modulates the
binding of the bone morphogenetic protein antagonist Noggin. J Biol Chem 279:
5604–5611.
45. Wang S, Ai X, Freeman SD, Pownall ME, Lu Q, et al. (2004) QSulf1, a heparan
sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in
mesoderm induction and angiogenesis. Proc Natl Acad Sci U S A 101:
4833–4838.
46. Uchimura K, Morimoto-Tomita M, Bistrup A, Li J, Lyon M, et al. (2006) HSulf-
2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-
bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1.
BMC Biochem 7: 2.
Sulf1&2: Redundant & Essential
PLoS ONE | www.plosone.org 14 June 2007 | Issue 6 | e575